Buzzing stock: JB Chemicals & Pharmaceuticals makes new 52-week high

During Tuesday’s trading session, even as Sensex and Nifty remained volatile, the stock of JB Chemicals & Pharmaceuticals has hit a new 52-week high.

JB Chemicals & Pharmaceuticals emerged as one of the top pharmaceuticals stock gainers on Tuesday. The stock jumped more than 16 per cent and made a new 52-week high of Rs 965 on BSE.

Gaining for the second consecutive trading session, the stock of JB Chemicals & Pharmaceuticals has recovered by 115.88 per cent from its sharp decline in March 2020. On a YTD basis, the stock has gained by 110.84 per cent. It has given returns of 27.10 per cent, 77.36 per cent and 127.35 per cent for 3 months, 6 months, and 1 year, respectively.  According to BSE data, the stock traded at a P/E multiple of 19.39 and a price-to-book ratio of 4.44.

The stock is rising because of good quarterly results. The consolidated net profit in Q1FY21 came in at Rs 119.5 crore, which rose by 92.4 per cent, as compared to Q1FY20 when it had reported a profit of Rs 62.11 crore.

JB Chemicals & Pharmaceuticals is one of India’s fastest-growing pharmaceutical companies. An integrated, research-oriented, public-listed organisation with a focus on supplying affordable, quality products both in India and international markets, JBCPL is trusted by healthcare professionals globally. As per the recent data, JBCPL exports to over 30 countries across the world and earns more than half of its revenue from international businesses.